Joana Fernandes, PhD,  —

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

Articles by Joana Fernandes

FDA Approves Xadago as Add-on for Parkinson’s Patients on Levodopa/Carbidopa

The U.S. Food and Drug Administration (FDA) has approved Xadago (safinamide) as an add-on therapy to increase the effectiveness of levodopa/carbidopa in Parkinson’s disease. Xadago limits the number of  “off” episodes, or increases in symptoms, among patients on levodopa/carbidopa, clinical trials have shown. “Parkinson’s is a relentless disease without a cure,” Eric Bastings,…

Short Exposure to Air Pollution May Increase Parkinson’s Risk, Korean Study Shows

Even brief exposure to air pollution can increase the risk of Parkinson’s disease and other neurological diseases, concludes a Korean study. The study, “Short-term air pollution exposure aggravates Parkinson’s disease in a population-based cohort,” appeared in the journal Scientific Reports. Various environmental factors contribute to the pathology of Parkinson’s, but air…